|
1
|
Choong PF, Mok PL, Cheong SK, Leong CF and
Then KY: Generating neuron-like cells from BM-derived mesenchymal
stromal cells in vitro. Cytotherapy. 9:170–183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu R, Jiang X, Guo Z, Chen J, Zou Y, Ke Y,
Zhang S, Li Z, Cai Y, Du M, Qin L, Tang Y and Zeng Y: Functional
analysis of neuron-like cells differentiated from neural stem cells
derived from bone marrow stroma cells in vitro. Cell Mol Neurobiol.
28:545–558. 2008. View Article : Google Scholar
|
|
4
|
Cui X, Chen L, Ren Y, Ji Y, Liu W, Liu J,
Yan Q, Cheng L and Sun YE: Genetic modification of mesenchymal stem
cells in spinal cord injury repair strategies. Biosci Trends.
7:202–208. 2013.PubMed/NCBI
|
|
5
|
Kode JA, Mukherjee S, Joglekar MV and
Hardikar AA: Mesenchymal stem cells: immunobiology and role in
immunomodulation and tissue regeneration. Cytotherapy. 11:377–391.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
da Meirelles LS, Fontes AM, Covas DT and
Caplan AI: Mechanisms involved in the therapeutic properties of
mesenchymal stem cells. Cytokine Growth Factor Rev. 20:419–427.
2009. View Article : Google Scholar
|
|
7
|
Davies OG, Smith AJ, Cooper PR, Shelton RM
and Scheven BA: The effects of cryopreservation on cells isolated
from adipose, bone marrow and dental pulp tissues. Cryobiology.
69:342–347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bakhshi T, Zabriskie RC, Bodie S, Kidd S,
Ramin S, Paganessi LA, Gregory SA, Fung HC and Christopherson KW
II: Mesenchymal stem cells from the Wharton’s jelly of umbilical
cord segments provide stromal support for the maintenance of cord
blood hematopoietic stem cells during long-term ex vivo culture.
Transfusion. 48:2638–2644. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moretti P, Hatlapatka T, Marten D,
Lavrentieva A, Majore I, Hass R and Kasper C: Mesenchymal stromal
cells derived from human umbilical cord tissues: primitive cells
with potential for clinical and tissue engineering applications.
Adv Biochem Eng Biotechnol. 123:29–54. 2010.
|
|
10
|
Lisianyĭ MI: Mesenchymal stem cells and
their immunological properties. Fiziol Zh. 59:126–134. 2013.(In
Ukranian).
|
|
11
|
Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS,
Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, et al: Comparison of
immunomodulatory properties of mesenchymal stem cells derived from
adult human tissues. Cell Immunol. 259:150–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H
and Fu YS: Transplantation of human umbilical mesenchymal stem
cells from Wharton’s jelly after complete transection of the rat
spinal cord. PLoS One. 3:e33362008. View Article : Google Scholar
|
|
13
|
Ma H, Wu Y, Xu Y, Sun L and Zhang X: Human
umbilical mesenchymal stem cells attenuate the progression of focal
segmental glomerulosclerosis. Am J Med Sci. 346:486–493. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gronthos S, Mankani M, Brahim J, Robey PG
and Shi S: Postnatal human dental pulp stemcells (DPSCs) in vitro
and in vivo. Proc Natl Acadm Sci USA. 97:13625–13630. 2000.
View Article : Google Scholar
|
|
15
|
Zhao Y, Wang L, Jin Y and Shi S: Fas
ligand regulates the immunomodulatory properties of dental pulp
stem cells. J Dent Res. 91:948–954. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kermani AJ, Fathi F and Mowla SJ:
Characterization and genetic manipulation of human umbilical cord
vein mesenchymal stem cells: potential application in cell-based
gene therapy. Rejuvenation Res. 11:379–386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhowmick R and Girotti AW: Cytoprotective
signaling associated with nitric oxide upregulation in tumor cells
subjected to photodynamic therapy-like oxidative stress. Free Radic
Biol Med. 57:39–48. 2013. View Article : Google Scholar :
|
|
18
|
Kikuchi-Taura A, Taguchi A, Kanda T, Inoue
T, Kasahara Y, Hirose H, Sato I, Matsuyama T, Nakagomi T, Yamahara
K, et al: Human umbilical cord provides a significant source of
unexpanded mesenchymal stromal cells. Cytotherapy. 14:441–450.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fink KD, Rossignol J, Crane AT, Davis KK,
Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L
and Dunbar GL: Transplantation of umbilical cord-derived
mesenchymal stem cells into the striata of R6/2 mice: behavioral
and neuropathological analysis. Stem Cell Res Ther. 4:1302013.
View Article : Google Scholar :
|
|
20
|
Trapnell C, Pachter L and Salzberg SL:
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics.
25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trapnell C, Roberts A, Goff L, Pertea G,
Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L:
Differential geneand transcript expressionanalysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baron F and Storb R: Mesenchymal stromal
cells: a new tool against graft-versus-host disease? Biol Blood
Marrow Transplant. 18:822–840. 2012. View Article : Google Scholar :
|
|
23
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mangano C, De Rosa A, Desiderio V,
d’Aquino R, Piattelli A, De Francesco F, Tirino V, Mangano F and
Papaccio G: The osteoblastic differentiation of dental pulp stem
cells and bone formation on different titanium surface textures.
Biomaterials. 31:3543–3551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fukuda S, Foster RG, Porter SB and Pelus
LM: The antiapoptosis protein survivin is associated with cell
cycle entry of normal cord blood CD34(+) cells and modulates cell
cycle and proliferation of mouse hematopoietic progenitor cells.
Blood. 100:2463–2471. 2002. View Article : Google Scholar : PubMed/NCBI
|
